揚(yáng)子江藥業(yè)集團(tuán)持續(xù)強(qiáng)化藥品企業(yè)質(zhì)量意識(shí)保障消費(fèi)者用藥安全
發(fā)布時(shí)間：
2022-11-16
作者：
本報(bào)訊 （李吟男）日前，揚(yáng)子江藥業(yè)集團(tuán)召開(kāi)專題會(huì)議，組織集團(tuán)及各子公司生產(chǎn)、質(zhì)量、研發(fā)、供應(yīng)部門負(fù)責(zé)人集中學(xué)習(xí)討論，貫徹黨中央、國(guó)務(wù)院關(guān)于****疫苗事件會(huì)議精神，傳達(dá)江蘇泰州市藥品安全監(jiān)管會(huì)議精神，進(jìn)一步提高藥品生產(chǎn)企業(yè)的質(zhì)量意識(shí)。
揚(yáng)子江藥業(yè)集團(tuán)總經(jīng)理助理梁元太說(shuō)，****疫苗事件暴露出相關(guān)單位在落實(shí)藥品安全方面的嚴(yán)重失職，特別存在重大風(fēng)險(xiǎn)隱患信息不報(bào)告、應(yīng)急處置不力等問(wèn)題。對(duì)此，黨中央、國(guó)務(wù)院要求抓緊完善相關(guān)法律法規(guī)，健全最嚴(yán)格的藥品監(jiān)管體系，完善疫苗全鏈條監(jiān)管和電子追溯等制度，堵塞監(jiān)管漏洞，推動(dòng)國(guó)產(chǎn)疫苗技術(shù)升級(jí)，切實(shí)保障消費(fèi)者用藥安全。
據(jù)悉，**疫苗事件發(fā)生后，泰州市也召開(kāi)了進(jìn)一步加強(qiáng)藥品安全監(jiān)管工作會(huì)議。泰州市副市長(zhǎng)王學(xué)鋒要求各部門深入排查整改藥品安全源頭性、區(qū)域性風(fēng)險(xiǎn)隱患，從源頭上嚴(yán)防嚴(yán)控藥品生產(chǎn)、流通各環(huán)節(jié)安全風(fēng)險(xiǎn)，確保管理責(zé)任到位，監(jiān)督職責(zé)到位，應(yīng)對(duì)處置舉措到位，努力保障人民群眾用藥安全。
揚(yáng)子江藥業(yè)集團(tuán)執(zhí)行總經(jīng)理梁宏指出，生產(chǎn)企業(yè)是藥品質(zhì)量責(zé)任的主體，對(duì)企業(yè)的要求是依法依規(guī)和守住道德底線。****疫苗事件為所有制藥企業(yè)及藥品監(jiān)管部門敲響了警鐘，并再一次驗(yàn)證了質(zhì)量是企業(yè)立身之本，管控藥品生產(chǎn)的全周期，確保藥品安全有效、質(zhì)量可控，將是揚(yáng)子江藥業(yè)集團(tuán)對(duì)藥品質(zhì)量的承諾。梁宏要求集團(tuán)各部門結(jié)合即將開(kāi)展的第40次“質(zhì)量月”活動(dòng)，進(jìn)一步探討如何加強(qiáng)質(zhì)量管理，并提出具體的改進(jìn)措施。在第40次“質(zhì)量月”活動(dòng)驗(yàn)收時(shí)，揚(yáng)子江藥業(yè)集團(tuán)將組織一次全面的大檢查，特別要集中現(xiàn)場(chǎng)檢查，確保各生產(chǎn)環(huán)節(jié)合規(guī)合法。
長(zhǎng)期以來(lái)，揚(yáng)子江藥業(yè)集團(tuán)憑借高效優(yōu)質(zhì)的產(chǎn)品，在市場(chǎng)上贏得了良好口碑，獲得了中國(guó)質(zhì)量獎(jiǎng)提名獎(jiǎng)、全球卓越績(jī)效獎(jiǎng)、質(zhì)量標(biāo)桿企業(yè)等榮譽(yù)。作為藥品生產(chǎn)企業(yè)，揚(yáng)子江人從未掉以輕心，時(shí)刻反省自危，時(shí)刻牢記“任何困難都不能把我們打倒，唯有質(zhì)量”的質(zhì)量精神，始終踐行“為父母制藥，為親人制藥”的質(zhì)量文化，堅(jiān)持質(zhì)量零缺陷，誠(chéng)信生產(chǎn)，為集團(tuán)發(fā)展保駕護(hù)航。
《中國(guó)國(guó)門時(shí)報(bào)》
Yangzi Pharmaceutical Group continues to strengthen quality awareness of pharmaceutical companies to protect consumers' medication safety
A few days ago, Yangzijiang Pharmaceutical Group held a special meeting to organize the leaders of the production, quality, research and development, and supply departments of the group and its subsidiaries to study and discuss, to implement the spirit of the CPC Central Committee and the State Council meeting on the ** vaccine incident, and to convey the spirit of the Jiangsu Taizhou Drug Safety Supervision Conference. Improve the quality awareness of pharmaceutical manufacturers.
Liang Yuantai, assistant general manager of Yangzijiang Pharmaceutical Group, said that the **** vaccine incident exposed serious dereliction of duty in the implementation of drug safety by relevant units, especially the lack of reporting of information on major risks and inadequate emergency response. In this regard, the Party Central Committee and the State Council require that relevant laws and regulations be improved, the most stringent drug regulatory system be perfected, the whole chain of vaccine supervision and electronic traceability be improved, loopholes in supervision be plugged, domestic vaccine technology upgraded, and consumers'medication safety be effectively guaranteed.
It is reported that after the ** vaccine incident, Taizhou City also held a meeting to further strengthen drug safety supervision. Wang Xuefeng, deputy mayor of Taizhou City, asked all departments to thoroughly investigate and rectify the hidden dangers of the source and regional risks of drug safety, strictly guard against and control the safety risks in all links of drug production and circulation from the source, ensure that the management responsibility is in place, supervise responsibility is in place, and deal with measures in place to ensure the safety of drug use by the people.
Liang Hong, executive general manager of Yangzijiang Pharmaceutical Group, pointed out that the manufacturing enterprises are the main body of drug quality responsibility, and the requirement for enterprises is to abide by the law and keep the moral bottom line. **** The vaccine incident has sounded an alarm bell for all pharmaceutical enterprises and drug regulatory authorities. It has once again proved that quality is the foundation of an enterprise. It is the promise of Yangzijiang Pharmaceutical Group to control the whole cycle of drug production and ensure the safety, effectiveness and quality control of drugs. Liang Hong asked all departments of the group to further explore how to strengthen quality management and put forward specific improvement measures in the light of the forthcoming 40th "Quality Month" activity. In the 40th "Quality Month" activity acceptance, Yangzijiang Pharmaceutical Group will organize a comprehensive inspection, especially on-site inspection, to ensure that all production links comply with the law.
For a long time, Yangzijiang Pharmaceutical Group has won a good reputation in the market by virtue of its high efficiency and high quality products, and won the awards of China Quality Award nomination, Global Excellent Performance Award, and quality benchmarking enterprises. As a pharmaceutical manufacturer, Yangzijiang people never take it lightly, always reflect on their own dangers, always keep in mind the quality spirit of "no difficulty can knock us down, only quality", always practice the quality culture of "pharmaceutical for parents, pharmaceutical for relatives", adhere to the quality of zero defect, honest production, the development of the Group to ensure the driving force Escort.
China National times